Dapagliflozin in combination therapy for treating type 2 diabetes

Technology appraisal guidance
Reference number: TA288
Published: 26 June 2013
Last updated: 23 November 2016

Diabetes (type 2) - dapagliflozin: final appraisal determination document

Diabetes (type 2) - dapagliflozin: final appraisal determination document

Diabetes (type 2) - dapagliflozin: final appraisal determination document
30 May 2013
(479.84 Kb 19 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 29 May 2013